ArticleFrontiers in medicine2025
The correlation between the uric acid to high-density lipoprotein cholesterol ratio and stroke.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The uric acid to high-density lipoprotein cholesterol ratio (UHR) is emerging as a novel biomarker reflecting the balance between pro-oxidative and antioxidative pathways. While implicated in various cardiometabolic diseases, its specific correlation with stroke risk, particularly across diverse populations, remains insufficiently characterized. This study aimed to investigate the UHR-stroke link in two independent populations. Methods: This cross-sectional analysis utilized data from 27,439 NHANES participants (2007-2018). We employed survey-weighted multivariable logistic regression to model the UHR-stroke correlation, complemented by restricted cubic splines (RCS) for dose-response relationships and subgroup analyses to assess effect modification. Furthermore, an external validation dataset comprising 1780 patients from The Central Hospital of Shaoyang was recruited to independently validate the primary findings. Results: A significant positive correlation was consistently observed between elevated UHR levels and increased stroke risk in both populations. Each unit increase in UHR corresponded to an adjusted OR of 1.03 (95% CI: 1.01-1.05) in NHANES and 1.06 (95% CI: 1.02-1.10) in the Chinese dataset. Similarly, an increasing trend in risk was evident across higher UHR quartiles. Dose-response trends were evident in both datasets ( Conclusion: UHR is consistently and positively associated with stroke risk in both U.S. and Chinese populations. These findings, derived from multi-ethnic and external validation dataset, strengthen the evidence for UHR as a practical biomarker for stroke risk assessment, potentially reflecting underlying oxidative-antioxidant imbalance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.